Results for:(81 found)
Dec 19, 2012 9:26AM on Top StocksBy Stock Traders Daily

With the help of an imaging agent, the pharma is pursuing what it hopes will be a blockbuster drug.

Dec 18, 2012 8:06AM on Top StocksBy Benzinga

Optimism that a budget agreement is close could extend equities' rally.

Dec 13, 2012 12:48PM on Top StocksBy MSN Money Partner

Darden is downgraded to 'neutral,' and Burger King is initiated with a 'buy.'

Nov 20, 2012 10:25AM on Top StocksBy Stock Traders Daily

Even with the prospect of dividend taxes going up, my sense is that income-generating stocks will remain in favor going forward.

Nov 7, 2012 12:15PM on Top StocksBy Minyanville.com

The pharma wins US approval for a new rheumatoid arthritis pill, but Abbott's existing treatment isn't likely to suffer a meaningful hit to sales anytime soon.

Oct 26, 2012 2:33PM on Top StocksBy Minyanville.com

The stock falls after investors get a peek at the royalty-rate structure that pharma giant Roche will pay if a promising new cancer drug is approved.

Oct 23, 2012 11:56AM on Top StocksBy Stock Traders Daily

The pharma's earnings may not look great, but bailing out could prove costly for investors if its Alzheimer's drug is successful.

Oct 17, 2012 9:00AM on Top StocksBy Jim Cramer

If you aren't in 1 of these 3 areas, you are playing an earnings-and-macro game that rides more on luck than skill.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More